{"id":"https://openalex.org/W3082277945","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-07","title":"Abstract OT-13-07: Phase I study of adoptive immunotherapy for advanced MUC1* positive breast cancer with autologous T cells engineered to express a chimeric antigen receptor, huMNC2-CAR44 specific for a cleaved form of MUC1 (MUC1*)","display_name":"Abstract OT-13-07: Phase I study of adoptive immunotherapy for advanced MUC1* positive breast cancer with autologous T cells engineered to express a chimeric antigen receptor, huMNC2-CAR44 specific for a cleaved form of MUC1 (MUC1*)","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3082277945","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-07","mag":"3082277945"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ot-13-07","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024804370","display_name":"Jennifer M. Specht","orcid":"https://orcid.org/0000-0003-1484-2113","observed_orcids":["https://orcid.org/0000-0003-1484-2113"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Marie Specht","raw_affiliation_strings":["1University of Washington, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Washington, Seattle, WA;","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016684714","display_name":"David G. Maloney","orcid":"https://orcid.org/0000-0002-8477-6919","observed_orcids":["https://orcid.org/0000-0002-8477-6919"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Maloney","raw_affiliation_strings":["2Fred Hutchinson Cancer Research Center, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fred Hutchinson Cancer Research Center, Seattle, WA;","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064100640","display_name":"Cecilia C.S. Yeung","orcid":"https://orcid.org/0000-0001-6799-2022","observed_orcids":["https://orcid.org/0000-0001-6799-2022"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cecilia Yeung","raw_affiliation_strings":["2Fred Hutchinson Cancer Research Center, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fred Hutchinson Cancer Research Center, Seattle, WA;","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027819567","display_name":"Qian Vicky Wu","orcid":"https://orcid.org/0000-0002-2292-4816","observed_orcids":["https://orcid.org/0000-0002-2292-4816"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qian (Vicky) Wu","raw_affiliation_strings":["2Fred Hutchinson Cancer Research Center, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fred Hutchinson Cancer Research Center, Seattle, WA;","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018975449","display_name":"Cynthia Carol Bamdad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114620","display_name":"Minerva Biotechnologies (United States)","ror":"https://ror.org/02dq1ca65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114620"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Bamdad","raw_affiliation_strings":["3Minerva Biotechnologies, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Minerva Biotechnologies, Waltham, MA","institution_ids":["https://openalex.org/I4210114620"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"OT","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/muc1","display_name":"MUC1","score":0.7559999823570251},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8240000009536743},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.8240000009536743},{"id":"https://openalex.org/keywords/autologous-t-cells","display_name":"autologous T cells","score":0.8299999833106995},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/lentiviral-vectors","display_name":"lentiviral vectors","score":0.7149999737739563},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.6499999761581421},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7368564605712891},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.5975074172019958},{"id":"https://openalex.org/C2777421810","wikidata":"https://www.wikidata.org/wiki/Q21145188","display_name":"MUC1","level":3,"score":0.5573917031288147},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5194417834281921},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5003039836883545},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.49387603998184204},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.48927685618400574},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.4614085257053375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45521068572998047},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.45496493577957153},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4473242461681366},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4182267189025879},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.41219207644462585},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.39155998826026917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25993919372558594},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22720518708229065},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22199833393096924},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.1657104194164276},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.061895519495010376}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ot-13-07","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4241563598","https://openalex.org/W3169208943","https://openalex.org/W4393986401","https://openalex.org/W4281734146","https://openalex.org/W4400265546","https://openalex.org/W2945913760","https://openalex.org/W4396590647","https://openalex.org/W3098131141","https://openalex.org/W4249886173","https://openalex.org/W4362541391"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Chimeric":[2],"antigen":[3,65,176,539],"receptor":[4],"(CAR)":[5],"T":[6,31,68,76,101,145,167,195,204,211,302,320,341,350,361,400,464,532],"cell":[7,32,69,362,401,465],"therapy":[8,33],"targeting":[9,112,398],"CD19":[10],"results":[11],"in":[12,152,178,197,326,352,367,374,388,439,455,476,486],"marked":[13],"tumor":[14,344,356,368,378],"regression":[15],"for":[16,66,524,543],"patients":[17,153,328,392,435,482,496],"with":[18,104,154,172,181,266,329,406,530],"B-cell":[19],"malignancies.":[20],"It":[21],"would":[22],"be":[23,437,484],"ideal":[24],"to":[25,34,90,149,249,274,294,343,432,450,460,472,480,535],"extend":[26],"the":[27,81,136,296,426,452,554],"success":[28],"of":[29,44,84,99,141,192,221,244,300,316,339,348,390,441,521,547,553],"CAR":[30,67,75,194],"common":[35],"epithelial":[36],"cancers.":[37],"MUC1*":[38,85,93,156,230,357,526],"is":[39,49,62,130,162,185,293,386,404,419,470],"a":[40,57,63,74,105,131,399,407,537,544],"post-translationally":[41],"modified/cleaved":[42],"form":[43,83,546],"mucin":[45],"1":[46,207],"(MUC1)":[47],"that":[48,78,403],"frequently":[50],"expressed":[51],"on":[52],"breast":[53,157,219,528],"tumors,":[54],"functions":[55],"as":[56],"growth":[58],"factor":[59],"receptor,":[60,540],"and":[61,86,120,124,138,165,175,183,225,259,307,314,322,359,364,376,413,423,448,459,474,489],"promising":[64],"therapy.":[70],"Minerva":[71],"Biotechnologies":[72],"developed":[73],"(huMNC2-CAR44)":[77],"specifically":[79],"recognizes":[80],"cleaved":[82,545],"does":[87],"not":[88,286],"bind":[89],"full-length":[91],"or":[92,234,240,262,270,384,497],"negative":[94],"cells.":[95],"huMNC2-CAR44":[96,151,193,301,319,340,349,360,463,541],"product":[97],"consists":[98],"autologous":[100,144,531],"cells":[102,146,168,196,303,321,342,351,533],"transduced":[103,171],"lentiviral":[106],"vector":[107],"encoding":[108],"humanized":[109],"MNC2-scFv":[110],"(MUC1*":[111],"head),":[113],"sequences":[114],"from":[115],"CD8":[116],"\u03b1;;":[117],"leader,":[118],"hinge":[119],"transmembrane":[121],"domains,":[122],"4-1BB":[123],"CD3\u03b6":[125],"domains.":[126],"Trial":[127],"Design:":[128,381],"NCT04020575":[129],"phase":[132],"I":[133,519],"study":[134,520],"evaluating":[135],"safety":[137],"anti-tumor":[139,453],"activity":[140,325,454],"adoptively":[142,317],"transferred":[143,318],"genetically":[147],"modified":[148],"express":[150,536],"metastatic":[155,218],"cancer.":[158],"After":[159],"screening,":[160],"leukapheresis":[161],"performed,":[163],"CD8+":[164],"CD4+":[166],"are":[169,285],"selected,":[170],"huMNC2-CAR44,":[173],"expanded,":[174],"stimulated":[177],"vitro.":[179],"Lymphodepletion":[180],"cyclophosphamide":[182],"fludarabine":[184],"followed":[186],"36-96":[187],"hours":[188],"later":[189],"by":[190,237,304,332,371],"infusion":[191],"escalating":[198],"doses":[199],"(3.3":[200],"x":[201,208],"105":[202],"CAR+":[203,210],"cells/kg":[205],"-":[206],"107":[209],"cells/kg).":[212],"Eligibility:":[213],"Key":[214],"inclusion":[215],"criteria":[216],"include":[217,312,337],"cancer":[220,529],"known":[222,248],"ER,":[223],"PR":[224],"HER2":[226,446],"status":[227],"which":[228],"has":[229,428],"membrane":[231],"expression":[232,358],">":[233,261,414],"=":[235,263],"30%":[236],"immunohistochemistry,":[238],"measurable":[239,330],"evaluable":[241],"disease,":[242],"receipt":[243],"standard":[245,395],"systemic":[246],"therapies":[247],"confer":[250],"benefit,":[251],"age":[252],">18,":[253],"informed":[254],"consent,":[255],"adequate":[256],"organ":[257],"function,":[258],"KPS":[260],"60%.":[264],"Patients":[265],"active":[267],"autoimmune":[268],"disease":[269,331],"uncontrolled":[271],"infection,":[272],"contraindication":[273],"cyclophosphamide,":[275],"anticipated":[276],"survival":[277],"<":[278,411],"3":[279,391,442],"months,":[280],"and/or":[281],"untreated":[282],"CNS":[283],"metastases":[284],"eligible.":[287],"Specific":[288],"Aims:":[289],"The":[290],"primary":[291],"objective":[292],"identify":[295],"maximum":[297],"tolerated":[298],"dose":[299,402,477,487],"CTCAE":[305],"v5":[306],"Lee":[308],"criteria.":[309],"Secondary":[310],"objectives":[311,336],"persistence":[313,363],"phenotype":[315],"preliminary":[323],"antitumor":[324],"all":[327],"RECIST":[333],"1.1.":[334],"Exploratory":[335],"trafficking":[338],"sites,":[345],"effector":[346],"function":[347],"vivo,":[353],"association":[354],"between":[355,420],"response,":[365],"change":[366],"immune":[369],"microenvironment":[370],"multiplex":[372],"immunohistochemistry":[373],"pre":[375],"post-treatment":[377],"biopsies.":[379],"Statistical":[380],"Dose":[382],"escalation":[383,488],"de-escalation":[385],"tested":[387],"cohorts":[389,444],"each":[393,440],"using":[394],"\"3+3\"":[396],"dose-finding":[397],"associated":[405],"true":[408],"DLT":[409,417],"rate":[410],"33%":[412],"than":[415],"17%.":[416],"period":[418],"day":[421],"0":[422],"28.":[424],"Once":[425],"MTD":[427],"been":[429],"determined,":[430],"up":[431],"15":[433],"more":[434,499],"will":[436],"enrolled":[438,485],"expansion":[443,490],"(Luminal,":[445],"positive,":[447],"TNBC)":[449],"estimate":[451],"these":[456],"patient":[457],"populations":[458],"inform":[461],"future":[462],"trials.":[466],"Present":[467],"accrual:":[468],"Study":[469],"open":[471],"screening":[473],"enrollment":[475],"escalation.":[478],"Up":[479],"69":[481],"may":[483],"phases.":[491],"Contact":[492],"information:":[493],"To":[494],"refer":[495],"obtain":[498],"information,":[500],"please":[501],"contact":[502],"immunotherapy@seattlecca.org.":[503],"Citation":[504],"Format:":[505],"Jennifer":[506],"Marie":[507],"Specht,":[508],"David":[509],"Maloney,":[510],"Cecilia":[511],"Yeung,":[512],"Qian":[513],"(Vicky)":[514],"Wu,":[515],"Cynthia":[516],"Bamdad.":[517],"Phase":[518],"adoptive":[522],"immunotherapy":[523],"advanced":[525],"positive":[527],"engineered":[534],"chimeric":[538],"specific":[542],"MUC1":[548],"(MUC1*)":[549],"[abstract].":[550],"In:":[551],"Proceedings":[552],"2020":[555,562],"San":[556,565],"Antonio":[557],"Breast":[558],"Cancer":[559,571],"Virtual":[560],"Symposium;":[561],"Dec":[563],"8-11;":[564],"Antonio,":[566],"TX.":[567],"Philadelphia":[568],"(PA):":[569],"AACR;":[570],"Res":[572],"2021;81(4":[573],"Suppl):Abstract":[574],"nr":[575],"OT-13-07.":[576]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2020-09-08T00:00:00"}